Corsini, Michela
 Distribuzione geografica
Continente #
NA - Nord America 3.404
EU - Europa 2.325
AS - Asia 1.887
SA - Sud America 331
AF - Africa 50
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.008
Nazione #
US - Stati Uniti d'America 3.335
PL - Polonia 710
SG - Singapore 613
CN - Cina 564
IT - Italia 488
BR - Brasile 283
DE - Germania 272
UA - Ucraina 245
HK - Hong Kong 218
VN - Vietnam 148
FI - Finlandia 135
GB - Regno Unito 127
TR - Turchia 72
RU - Federazione Russa 70
IN - India 62
IE - Irlanda 55
ES - Italia 40
NL - Olanda 38
FR - Francia 35
CA - Canada 33
ID - Indonesia 32
JP - Giappone 30
BD - Bangladesh 29
SE - Svezia 25
AR - Argentina 22
ZA - Sudafrica 22
BE - Belgio 21
MX - Messico 17
IR - Iran 15
CZ - Repubblica Ceca 14
AT - Austria 12
KR - Corea 12
IQ - Iraq 11
PH - Filippine 10
KG - Kirghizistan 8
PK - Pakistan 8
TH - Thailandia 8
AU - Australia 7
CH - Svizzera 7
EG - Egitto 7
MA - Marocco 7
CO - Colombia 6
LT - Lituania 6
EC - Ecuador 5
ET - Etiopia 5
GR - Grecia 5
KZ - Kazakistan 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
IL - Israele 4
JM - Giamaica 4
LK - Sri Lanka 4
MY - Malesia 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
MU - Mauritius 3
PA - Panama 3
RO - Romania 3
UY - Uruguay 3
UZ - Uzbekistan 3
CU - Cuba 2
EU - Europa 2
GE - Georgia 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PS - Palestinian Territory 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.008
Città #
Warsaw 706
Ashburn 401
Fairfield 314
Singapore 304
Brescia 219
Hong Kong 208
Woodbridge 182
Jacksonville 180
Chandler 177
Ann Arbor 170
Houston 149
Beijing 130
Seattle 111
Cambridge 105
New York 104
Los Angeles 101
Princeton 100
Wilmington 96
Dearborn 71
Helsinki 69
Munich 68
Milan 64
The Dalles 57
Dallas 56
Dublin 55
Istanbul 53
Nanjing 50
Dong Ket 41
San Francisco 40
Ho Chi Minh City 39
Buffalo 34
Chicago 34
São Paulo 34
Turku 34
Shanghai 31
Jakarta 26
Madrid 26
Des Moines 25
Shenyang 24
London 22
Moscow 21
Tokyo 21
Brussels 20
Washington 20
Hanoi 19
San Diego 19
Santa Clara 19
Hebei 17
Jinan 17
Lancaster 17
Nanchang 17
Council Bluffs 16
Redondo Beach 16
Nuremberg 15
Orem 14
Phoenix 14
Amsterdam 13
Guangzhou 13
Johannesburg 13
Tianjin 13
Boardman 12
Brooklyn 12
Hangzhou 12
Lappeenranta 12
Boston 11
Changsha 11
Denver 11
Frankfurt am Main 11
Atlanta 10
Brno 10
Chennai 10
Fara Gera d'Adda 10
Montreal 10
San Mateo 10
Haikou 9
Stockholm 9
Toronto 9
Zhengzhou 9
Ankara 8
Augusta 8
Bishkek 8
Hefei 8
Rio de Janeiro 8
Rome 8
Bangkok 7
Charlotte 7
Kunming 7
Mexico City 7
Paris 7
Chengdu 6
Guarulhos 6
Jiaxing 6
Mumbai 6
Naples 6
Padova 6
Porto Alegre 6
Redwood City 6
Bahir Dar 5
Brasília 5
Buenos Aires 5
Totale 5.378
Nome #
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 308
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 279
Claudin3 is localized outside the tight junctions in human carcinomas 275
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 260
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 253
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 213
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 212
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 205
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 201
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 197
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 193
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 188
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 187
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 180
Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis 162
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 161
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 157
VEGFR2 inattivo promuove la crescita tumorale modulando le caratteristiche meccaniche della matrice extra-cellulare 155
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 148
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 139
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 138
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 136
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors. 133
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 131
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 129
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 128
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 127
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 126
Role of VEGFs in metabolic disorders 124
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 121
Anti-angiogenic activity of the urokinase receptor-derived peptide UPARANT 120
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 117
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 116
Role of inflammation in FGF2-driven angiogenesis 113
Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform 113
lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR) 113
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 107
CHICK EMBRYO CAM/mES CELL-DERIVED TERATOMAS: A NOVEL MODEL TO STUDY TUMOR ANGIOGENESIS AND VASCULOGENESIS 103
Modeling cell motility and receptor dynamics 99
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 97
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 97
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 95
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 95
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 89
LONG PENTRAXIN-3 INHIBITS FGF-DEPENDENT ANGIOGENESIS AND GROWTH OF STEROID HORMONE-REGULATED TUMORS 86
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 86
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 86
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 85
The BMP antagonist DRM supports angiogenesis and tumor proression 83
Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop 81
Alternative method to visualize receptor dynamics in cell membranes 77
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 72
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 69
The contribution of obesogenic behavior on global warming 69
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 69
The D647N mutation of FGFR1 induces ligand-independent receptor activation 65
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 62
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 61
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer. 60
Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER + breast cancer 54
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 49
Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts 48
The impact of adipokines on vascular networks in adipose tissue 35
Protocol for performing angiogenic and tumorigenic assays using the in ovo chick embryo chorioallantoic membrane model 27
The mechanics of anoikis resistance in cancer 4
Lipid-Protein Interplay in the Regulation of Receptor Tyrosine Kinases 2
Totale 8.170
Categoria #
all - tutte 35.511
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.511


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021661 0 0 0 0 0 95 55 117 99 113 103 79
2021/2022471 35 79 11 18 8 27 30 26 30 61 40 106
2022/2023521 79 34 25 36 50 98 6 61 69 7 26 30
2023/2024774 41 43 84 52 44 126 46 58 113 41 25 101
2024/20251.513 47 15 23 233 134 130 138 81 152 97 263 200
2025/20261.813 300 335 217 424 366 171 0 0 0 0 0 0
Totale 8.170